Media Center

ETX0914 (AZD0914) designated a Qualified Infectious Disease Product (QIDP) and given Fast Track status by US FDA

AstraZeneca

Read the press release on AstraZeneca’s website:
AstraZeneca’s novel antibiotic candidate AZD0914 given Fast Track status by US FDA

 

Browse the Press Release archive. Bookmark the permalink.